New Study Reveals Method to Decode Precancerous Lung Lesions

Significance of Lung Cancer

A recent study published in Nature Medicine has identified a technique to decode the fate of precancerous lung lesions in the progression to invasive lung cancer. Lung cancer remains the most lethal cancer globally, accounting for approximately 1.8 million deaths worldwide in 2018. The disease occurs when abnormal cancer cells in the lungs multiply and form tumors. As these tumors grow, they begin to damage surrounding tissues and can metastasize, spreading to other areas of the body.

Understanding Pre-cancerous Lesions

Pre-cancerous lesions appear in the airways prior to the development of larger tumors. While abnormal cell growth can lead to cancer, not all tumors become malignant. In the initial stages, pre-cancerous lesions can be identified in the airways, with nearly half progressing to invasive cancer, while the other half remains benign and poses no threat.

Challenges in Current Detection Methods

Currently, the identification of cancerous lesions relies on laboratory analysis of lung tissue. However, both cancerous and benign samples appear identical under microscopic examination, complicating the distinction between lesions that will develop into invasive cancer and those that will not. This presents significant challenges in managing and treating lung cancer.

Research Advancements in Lesion Differentiation

The study conducted by researchers from University College London aimed to distinguish between invasive and non-invasive lesions. They analyzed 129 biopsies from 85 patients with pre-invasive lung cancer lesions, examining tissue at a cellular level to identify differences. Participants were monitored for an average of five years to determine which lesions progressed to lung squamous cell carcinoma, a prevalent type of lung cancer.

Molecular Profiles of Pre-cancerous Lesions

The findings indicated significant differences in the molecular profiles of the pre-cancerous lesions. Lesions that progressed to cancer exhibited molecular changes in gene and chromosome structures not present in benign lesions. These distinctions allowed for highly accurate predictions regarding which lesions would evolve into invasive cancer.

Implications for Early Detection and Treatment

Although not all at-risk patients undergo lung biopsies, the predictive tool developed in this study could facilitate early identification of lung cancer. Early detection is crucial for guiding treatment decisions, including the possibility of surgery or alternative interventions to remove lesions. Additionally, these results could lead to the development of new methods for detecting and treating lung cancer before it becomes more aggressive.

Need for Further Research

This study represents the largest examination of precancerous lung lesions to date. Some of the genes implicated in cancerous lesions are established markers for lung cancer, and the insights gained may illuminate their roles in cancer development. While more clinical studies are necessary before implementing these techniques in clinical practice, this research marks a significant advancement in the fight against lung cancer.

References

World Health Organization. Cancer [Internet]. Geneva, Switzerland: WHO; 2018 Sep 12 [cited 2019 Jan 26]. Available from: https://www.who.int/news-room/fact-sheets/detail/cancer
Teixeira VH, Pipinikas CP, Pennycuick A, Lee-Six H, Chandrasekharan D, Beane J, et al. Deciphering the genomic, epigenetic, and transcriptomic landscapes of pre-invasive lung cancer lesions. Nat Med. Epub 2019 Jan 21 [cited 2019 Jan 26]. Available from: https://www.nature.com/articles/s41591-018-0323-0 doi: 10.1038/s41591-018-0323-0
Lane C. Molecular profiling could catch lung cancer early and lead to new treatments [press release]. (2019 Jan 21) [cited 2019 Jan 26]. Available from: https://www.eurekalert.org/pub_releases/2019-01/ucl-mpc011819.php